Catalyst Wire Dossier Catalyst Wire Dossier

Hydromorphone (OROS)

hydromorphone · Xian-Janssen Pharmaceutical Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hydromorphone (OROS), covering 2013-08-26 to 2014-08-15. Get the full timeline:

Most recent: Clinical Trial Update: A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer [Phase 1]

See pricing